Medtech

  • Naitive receives FDA 510(k) clearance for AI-enabled opportunistic bone health assessment

    Naitive Technologies, a medical technology company developing AI-driven software to reimagine orthopedic care, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its flagship product, OsteoSight. OsteoSight enables opportunistic assessment of bone mineral density (BMD) using standard X-rays acquired to investigate other clinical concerns, such as pain [...]

  • Double C-loop lens proves rock-solid stability in landmark review

    Centre for Sight today announced the publication of a major international review paper co-authored by its Medical Director, Mr Sheraz Daya, highlighting the stability of a unique Double C-Loop intraocular lens (IOL) design. The peer-reviewed study — which analysed 19 clinical trials involving 1,428 eyes — concludes that the POD Double C-Loop platform provides exceptional [...]

  • Dentordu: Turkey’s digital dentistry pioneer with a UK pre-diagnosis office

    Fusing Turkish digital dentistry expertise with UK convenience Dentordu Oral and Dental Health Polyclinic, in Izmir, Turkey, is an innovative clinic that harnesses advanced technology to redefine the patient experience in dental care. Referrals to the clinic also come via a pre-diagnosis office in London, Dentordu UK. This enables UK patients to receive face-to-face consultations [...]

  • Caribbean students explore surgical robotics research at Leeds summer school

    Students from the Caribbean have been inspired to pursue careers in research during a visit to Leeds to work with surgical robotics. Students from the University of the West Indies and the University of Columbia took part in an eight week summer school programme in the STORM Lab at the University of Leeds. The CariSurg [...]

  • Scottish MedTech company launches NHS study to advance paediatric sleep diagnosis

    Glasgow-based MedTech company Seluna has announced the launch of a major clinical validation study with the Royal Hospital for Children in Glasgow in an effort to improve the diagnosis and management of childhood sleep disorders. The study, involving 500 anonymised patients under 18 years old, will run from now until the end of 2025. It [...]

  • Oxford spin-out acquired in ‘landmark’ £1.1bn deal

    OrganOx, a company that makes devices to keep organs alive outside the human body, has been bought by Japan’s Terumo Corporation in a “landmark” US$1.5bn (£1.1bn) deal. The Oxford University spin-out’s technology has preserved organs for transplantation and, according to its creators, has already saved 6,000 lives. The machines maintain organs by recreating body-like conditions [...]

  • ‘Skin in a syringe’ presents new way to heal burns

    Researchers have created a gel containing live cells that can be 3D printed into a skin transplant in what's being dubbed a 'skin in a syringe.' This technology, developed in Sweden, may lead to new ways to treat burns and severe wounds. Large burns are often treated by transplanting a thin layer of the top [...]

  • What if the biggest opportunity in healthcare isn’t more funding – but fewer inefficiencies?

    By Fiona Garín Mc Donagh, VP Strategic Marketing, BD EMEA What does sustainable healthcare really mean, not just for our planet, but for the people who deliver and receive care every day? Too often, sustainability is viewed only through the lens of environmental impact. While reducing carbon emissions and medical waste is of course critical, [...]

  • Study shows long-term benefit of implant for blinding disease

    A neuroprotective surgical implant can slow vision loss in people with a rare retinal disorder, according to a new study. There are currently no approved treatment options for people with macular telangiectasia type 2 (MacTel), an orphan retinal disorder that gradually destroys central vision. Professor Martin Friedlander of Scripps Research said: “This is a step [...]

  • Dxcover expands leadership with five appointments

    Dxcover, a clinical-stage oncology diagnostics company developing and commercialising its Multiomic Spectral Analysis platform (MOSA-Dx™), has announced the strategic expansion of its Scientific Advisory Board (SAB) and Board of Directors. These appointments bring world-class expertise across neurology, gynaecological and pancreatic oncology, clinical statistics, artificial intelligence, and commercial diagnostics - strengthening Dxcover’s position as it enters [...]